Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You read... that I repeatedly tried
.. they had no intention to allow other than the two.. Oppenheimer and another..
Back to you... did you join in the conference???
Conference call ended with only 2 questions asked... none about TPIV 200 ..metastatic breast cancer and Ovarisn cancer... I pressed ?1.. several times and was not recognized..
This was not an open process.
$347 million in losses most attributed to the TPIV lines... and no comment?
Seriously???
Once again... push the " hope" into 2021 and beyond...
PL... you seem to have the only way in..
Please, I sincerely ask you.. contact the company and ask for TPIV 200, 110 status... real status... would you..??
... your fellow deep underwater shareholders need a life line..
Revenues $-0-
Inception to date loss $348 million.
YTD LOSS: $20 Million.
Shares outstanding 47 million.
In PR.. MT-401.. pushed into 2021.
No mention of TPIV .. for metastatic breast cancer nor ovarian cancer.
FDA has not yet released from partial shut down, but anticipated.
Cash good to Q1, 2022..I don't see how based on 2020 burn rate..
Build out of manufacturing facility almost complete.
Not much volume in past few days and no price movement with one trading day left.
There is no dynamic interest in MRKR.
Sad to say it, much worse to see it next week... That Qtr. meeting is important.
If each and all of you are concerned about this sub basement share price fall from ~ $13. to now $1.39, and the future of MRKR, then you can have an actionable opportunity.
On Monday, at or before 5:00.pm EST..call 877-407-8913.. the quarter conference call to investors and interested parties.
This is a bio company, so LISTEN for science updates on each clinical study line.. the TPIV lines, the MARKER lines, and the adjuvant, now suspended.
What progress has been made?
What is future timing of each?
What kind of operations will take place in the 50,000 sq.foot rented space and when will it be operational?
What is the status of Capital and the current burn rate?
What opinions has the B of D offered, recommended, or ordered of management?
Likely, you will be allowed just one question.. so LISTEN and write you questions, using one not previously asked.
If you are complacent and ignore this opportunity.. you in effect forfeit your complaining on this board So, please commit and take action.. always being polite.. but demanding a solid response from management... remember, you are an owner of your company.
Short adding to my 553 post...
The Market Cap is $63 million ( a nano, not micro valuation).
If the company " Had the ' goods ' a big pharma could buy it with found change under the couch cushions in the CEO' office...
Lastly, I am not a basher holding several hundred thousand dollar losses here, just angry at an over paid, underperforming CEO and B o D.
MRKR low volume share price decline isn't from short selling... " Come on,man.." ( hee hee)..but from individuals giving up
A sale, a nibble, another sale, insufficient nibble.... on it goes, day after day, week after week, month after month.
There has never been a defense of the stock by the current CEO. There is your underlying reality.
Do they " have the goods?"
Only you can speculate...
Now $1.36... sickening... remember years ago...? When Kite went for $billions.. and the held position here was " we're worth more?".... look at today's market cap..
" Hope" has never been an investment.
Analysis? From what? Technical or fundamental or filings? There is nothing to analyze.
Daily trade volume is almost nothing, but it continue to dribble downwards.
If the company had something new and important, Reg FD requires making that public.
In 10 years, they have not close to FDA approval for any clinical study.
They command big compensation and have to many " experts."
I don't expect anything from the earnings call coming in 12 days... other than, we need much more capital.... yet another reverse split and issuance of more shares at a deep discount... Will that be the big point in the call?
I no longer believe in the manavenebr skills of Peter... and.... where is the Board of Directors required governance?
Save your breath with the " loyalty push back", at a $buck+, there is nothing here.
Oct.27 close:$1.53..
Last data update June 30.. facility rented.
14 days to earnings call, maybe Nov
10..
If prior to then, no positive, encouraging p/r's... share price will drop lower.. break a buck??
Thoughts?
Have they nothing to offer, nothing?
Again, I repeat my appreciation for PL..
What concerns me is 2016 TPIV..trials in breast and ovarian cancer and suggested a few years for results,the same in 2017 and 2018..and 19 and 20.. thus far: Nothing.
Then came the merger and further studies in AML and then pancreatic cancer.. once again 2 years.. now: Nothing. But, we hear wait a few years.. really?
Other bios will eat our lunch. Our lunch will need to be funded (dilution) yet again.
The Golden touch brothers ( read the web site) even with inside communication exchanges pulled out.. not good in any view point.
Like all, third quarter reporting better have some solid, measurable good data, or this is headed for the dumper and likely a legal issue..
Challenge this all you want, but 5+ years have produced nothing.
We are blinded by management and science and only the " loyalists- those who invest mainly with " hope" keep the fires going. We need open transparency. Wow a $1.62.. says it all.
Close $1.46, -.04, above average volume.. isn't that lovely... so promising
Reading the last several posts... what are some of you smoking???
If only you had knowledge of.the TPIV c/ phases.. you might have hope.. the AML and pancreatic studies.. don't even raise your hope for 2 more years and another dilution.
26 years of no results nor partnerships, just a successful grant write up by Mayo.
Our only board hope is PL and his ability to get some information..
Please... put the weed and or pills away..you're only killing yourself physically as well as financially..
Tomorrow is office golf or chess day.. the receptionist takes Monday off..
My bet.. long gone.
Micro, if there is another seat on that boat, not being claimed, put my name on it. I'll be right over.
Bwaaa haa haaa.. appreciate your thinking and closing humor... honestly
Han Scott, I read your response and pondered you 30430 post, trying to understand your position..
Isn't it accurate that Mayo and Baylor are doing the lab work?
If you agree and P/ clinic sites are already known, then until bigger positive results happen, I stand on my posit of asking about real effective hours being worked. This is not about the skills of the individuals. More like the " Maytag repair man."
I'm from a responsible state.. " Show me"
and as an investor, not a philanthropist, I want transparancy, the news, what I'd going on in each clinical trial, without vague, very occasional releases.
Who doesn't??
Thanks agaun6 for further DD.
I did notice that Polystart was first presented in 1988 morse.. and the current application was to Marker listing the anew Brighton,Mn. Address..
Still confused as to what it means for commercial use as in who wants it.. now after nant years, and it won't be examined for 3 months.. another 2021 deferral.
The company has lots of high priced talent and I often wonder how any or all fill there day... research done by others.. few calls, few tasks... I just wonder what is really going on.
More so, I wonder what the market place reaction would be IF just once there was a complete and honest disclosure of the trials..
Where are we with each TPIV project.
Where are we with Polystart.
Where are we with AML ( yes, last week words, I know)
Where are we with other hemo possibilities.
The capital is being expended.. will the only real news in early 2021 be... another reverse split and new share issuance?
Lastly, I would really like to know how the Board of Directors view the company objectively and guidance.
I think my post deserves opinion. When a company is vague tear after year... it us not taken seriously.. the current share price and market cap clearly reflects that.
But, thanks PL, Burr, and others.
Again PL, everyone appreciates your reporting and opinions.. very balanced, thanks.
At this time and during the past six + years, the only reason that the company continues to exist is from the dollar investments by retail and institutions.
It is new science dependent on millions of dollars.
What conflicts in my mind is this..and has been for 5+ years... TPIV focused on.breast and ovarian cancer... where are we and why is there no updates?
Polystart has been a vague science and now likely " back burner".. now an over sized lease with added staff... snd still they can't be clear as you found out.
I remain skeptical as I have been for 3 years.. and admittedly holding nearly 100,000 shares.. if only.. if only.
Greetings PL, all of us are pleased that you have a communication line to the company.
As you inferred, not much meat on the bone.
To gain an AML approval after P11 would be great as this disease is a short term killer. If MRKR gained a 50% penetration, I wonder what the revenue would be.
I also deeply wish updated results on the long testing of the TPIV linicsl.lines of which $ millions have been spent... while asking, why could the company not comment lightly on Polystart?
... I am no different than all other current investors clearly wanting to know more... to have hope... to see success.
Try to talk with them again? Good to hear from you..
Well said in a calm mostly objective post. Thank you.
When conversations between the company and Baker brothers yielded weak near term future results and adding in the share price massive decline ( now $1.53), it would be expected that post quarter analysis, they likely will pull out. If / when done, perception will be ' a lack of confidence, and the S/P will drop below $1.00 which triggers a whole new set of issues.
Bottom line, which during the next six months is grim. The only hope is that at that point Marker has more than one significant positive clinical results. A PR stating that plumbing, electrical, and sheet rock walls are complete won't cut it..
Personally, I have "grave" concerns about what management is doing above and below board.
I would really like to be proven wrong, but years into this have not been positive at all.... just dilution after dilution.
Thanks MD 2 B
MD2B..actually, I would appreciate your opinion and why... thanks..
Thus far today, a low of $1.44...
No defense of the stock price.
Below $5.00 eliminates large investors..
Small retail holders dribbling ' sella.'
Where will thus be in a month? Below a buck?
Anybody out there?
Markerman thanks, like others the second one concerning the buildout suggests more of AML clinical study support than anything about Polystart,, yes?
The first, was July 16, with review assignment in October. Having read it carefully, I see the registration of a error free submission but, I did not read ' as intended for Polystart manufacturing, yes?
As with others, thank you for popping up with DD.. we're serious about that, because a few of us have been here for more than 6 years.. filled with RS and share issuance dilution and we are weary knowing our average share cost is really a ove $13 and we receive no y/e share awards
However, you brightened my day.. thanks.
Hmmmmm.... thanks, even more useful if you provided the relevant DD.. would you?
I'd like to hear from BluMarlin1960 and his post 22892.. are you still holding or jumped ship with PL and the many strong willed supporters of the past 5 years.
I understand your assertion, but I ask, clearly ask of anyone...
50,000 square feet of space... to do exactly, specifically what?
Also, what is the clear pathway to the above? Honestly, none of us know the real details and timeline for any or all of the trials outcome.
How about Polystart? Wasn't that science start on the late 1990's? What is that. As a commercial item?
Remember, this is NOT a nonprofit organization seeking donations and grants... this is a public company, with a Federal ID, listed to grow and produce a maximized profit. Management needs to respond as though it knows it.
Thanks MD tb..
Investment reality... MRKR moved up in stock exchanges to be above $5.00..
Now, at $1.60 we are declining toward the delisting issues.
Other than we few bag holders, an outsider, without corporate updates, will never buy shares, because they now doubt bio success and distribution success.
Some days, I wonder how many of the highly compensate exec's fill their day... HR, Finance, marketing and communications.
I have a well known oncologist in AML and CML... never heard of Marker Therapeutics.. Why not?
An oncologist, Dr.Stephan Hahn, heads the FDA as its commissioner.
Yesterday, in a positive action, the FDA gave EUA ( Emergency Use Authorization) to Convalescence plasma as a therapeutic treatment for CV -19.
FDA tools available:
" Right to try"
EUA
Fast Track
Orphan drug status.
I can only hope that our VP in charge of FDA approval process is doing everything possible to move the TPIV pipeline and MRKR pipeline forward for approval. I hope for a change in attitude regarding much better communications with the medical practitioners, the shareholders, and the public.
Are either of these or both probable?
Understood.... no comments on bio competitors who are out pacing MRKR?
Wouldn't a buy out offer be certain if MRKR had the real goods?
The current share price doesn't correlate with the presented pipeline. What is really going on?
No news? No comments? No interest?
No posters?
Days going by....
If this is the qtr. Release day and MD&A..
The market which always gets beforehand leaks is not impressed.. down again..
I notice that old time posters have abandoned this board... Yahoo, the same.
If good things are in process, then there should be a change of corporate attitude and be transparent and communicative.
I know other than me and you... who cares.
Is MRKR reporting quarter 2 tomorrow or when.. wouldn't it be nice if they made the date known in a pr?
Even in my disappointment with corporate communications and transparancy, after all we have been through these past years, this is a shareholder owned public company. I bought 7,000 today, now holding 70,000 shares and I hope to be self vindicated late 2021..
No, I dont think so, and thinking, correctly or incorrectly, is all we have..
TPIV 100,110,200 was last updated July, a year ago, and now 3 years from 2017 when they did report very favorable pre clinic and phase 1\2 results... those of us in then were so encouraged, that an additional medical tool was about to be available with DoD funding, fast track, and orphan status granting... then we asked, what more could you want in a company... then with P.H. all went dark, and we became discouraged during the three years. Pumpers and loyalists have faded into the night.
The combined Marker, with new and additional promise still remains behind the big dark curtain. Only the stage crew has any insight. I could blather on, but I would ask... regarding the 48,000 now leased building and set up as operational in 2021, with haste, what are the plans for its use.. our clinical production or for third party availability? We deserve to know. Or, have certain things happened including research protection at Baylor that propriety use had to take place?
Don't you think a well worded disclosure is appropriate?
The FDA lifted its hold. COVID has not stopped other bio science public companies.. come on, what DO you think?
In 2017, then Tapimune, was touting success in clinical TPIV 110 and others
. Now 3 years later, where are they at?
Any one have accurate DD on the current status and future? Seems like those studies were all that the company had as any value, now as Marker, we should have transparency.... some data beyond the 48 k building lease and plans..
Anybody out there?
Don't feel offended... almost all retail and houses are deep underwater. Everyone is disgusted with the lack of transparency and communication. Unless you are in your 20's or 30's, you are definately concerned and helpless.
There are a few around who have no tact at all... let 'em be... you choice, my choice is to hold with ulceration or sell at big losses... I can't do the later.
Gl..
Comments about PL are accurate, he is around but, nothing to comment on... same as Blu.. my question is: where is RK Matters...?
K.Dart tosses back to MRKR 400,000 + warrants from 2015 exercisable at $15.. DOD not come close.
Then MRKR adds to employee benefit plan in the millions... I ask how about tied to success and investor recapturing of great losses..? Naw, why do that dilution is so much easier..
Consider a new possible retail investor who is experienced, excluding hope and loyalty emotions to MRKR, what realistic data and success projection would be compelling?
Micro... that was already done for you.and my bill is higher.. and I don't know if the fries will come HOT or cold.
Exactly, add my order to yours..but, how long before it is ready.... two months... two years????